Source: Virtual Congress 2021 – Biomarkers in early-detection of lung cancer: current concepts



Rating:

Share or cite this content

Citations should be made in the following way:
L. Montuenga (Pamplona (Navarra), Spain). Biomarkers in early-detection of lung cancer: current concepts. Virtual Congress 2021 – Biomarkers in early-detection of lung cancer: current concepts

Member's Comments

No comment yet.

Related content which might interest you: Lung disease induced by newer therapies for lung cancer: an update Source: Annual Congress 2006 - Drug-induced lung injury – new aspects Year: 2006 Lung cancer screening in never-smokers: facts and remaining issues Source: Eur Respir J, 56 (5) 2002949; 10.1183/13993003.02949-2020 Year: 2020 Milestones in the management of lung cancer Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Endpoints in IPF and lung cancer trials: controversies and perspectives Source: Research Seminar 2015 Year: 2015 Radiomics in lung cancer: progress and challenges Source: Virtual Congress 2021 – Chinese programme 2021 Year: 2021 Modern staging in lung cancer: from the current multidisciplinary process to novel approaches Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 The electronic nose: emerging biomarkers in lung cancer diagnostics Source: Breathe, 15 (4) e135; 10.1183/20734735.0309-2019 Year: 2019 Common therapeutic approaches in IPF and lung cancer Source: Research Seminar 2015 Year: 2015 New and anticipated therapeutic developments in management of non-small-cell lung cancer Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer Year: 2013 Screening for lung cancer - Opportunities and challenges Source: Short video statement 2020 Year: 2020 Biomarkers for non-small cell lung cancer (NSCLC) treatment: examples and unmet needs, a clinical perspective Source: International Congress 2014 – From bench to bedside: biomarkers and biobanking for lung cancer in 2014 Year: 2014 Exploiting metabolomic approaches to aid in the diagnosis of lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Biomarkers for lung cancer screening Source: Annual Congress 2011 - PG20 Biomarkers in respiratory medicine Year: 2011 Evolution in the diagnostic approach to lung cancer Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 Innovative local therapies in lung cancer Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy Year: 2018 Targeted therapies for lung cancer: how did the game begin? Source: Breathe 2016; 12: 177-179 Year: 2016 Issues other than tissue: non-invasive biomarkers of early stage lung cancer Source: Virtual Congress 2020 – Will the pulmonologist still play a role in the management of screen-detected pulmonary nodules? Year: 2020